52
Altay Therapeutics raises $45.07M in first Regulation D offering
Company raise · Raising · SAN CARLOS, CA · Form D filed 2026-10-02
Altay Therapeutics, a Delaware biotech corporation based in San Carlos, California, is raising $45.07M under Regulation D exemption 06b. The company has sold $15.74M to 19 investors so far and has $29.33M remaining in the offering.
$10M+ raiseFirst raise on EDGARoperating_company
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| JAMES BREITMEYER | Executive Officer, Director |
| ALI OZES | Executive Officer |
| ERIC BJERKHOLT | Director |
| MIKE GREY | Director |
| ESTER SKLARSKY | Director |
| AIDAN KING | Director |
| CHELSEA JOHNSON | Director |
Signed by James Breitmeyer, CEO.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.